Associate Professor of Surgery, Harvard Medical School; Co-Director, Endovascular Surgery
Brigham and Women's Hospital
Vascular Surgery
Boston, Massachusetts, United States
Dr. Matthew Menard graduated summa cum laude, phi beta kappa and with departmental high honors from Middlebury College. He attended Harvard Medical School and received his general surgery training at the Massachusetts General Hospital and vascular surgery fellowship training at the Brigham and Women’s Hospital. He is currently Co-Director of Endovascular Surgery and the former Vascular and Endovascular Surgery Fellowship Director at the Brigham and Women’s Hospital and is an Associate Professor of Surgery at Harvard Medical School. His clinical practice spans the gamut of vascular surgical disease, with a focus on chronic limb threatening ischemia (CLTI) and complex wound care.
Dr. Menard conceived and is a National Principal Investigator of the BEST-CLI Trial, an NIH-sponsored and FDA-endorsed investigation of the comparative-effectiveness of open surgery and endovascular therapy for chronic limb threatening ischemia (CLTI). BEST-CLI was a randomized, controlled trial involving more than 150 clinical sites globally that examined treatment efficacy, functional outcomes, cost and cost-effectiveness associated with endovascular or open surgical revascularization in patients with CLTI. Dr. Menard, along with collaborators at Boston Medical Center, Massachusetts General Hospital and Kolding/Lillebælt Hospital in Denmark, recently received a $4 million grant from the Novo Nordisk Foundation to extend the analysis of this landmark trial, establish a core angiographic imaging laboratory at BWH and investigate the health economics of CLTI care globally.
What Is the Target Arterial Pathway, and Why Does it Matter?
Sunday, November 2, 2025
3:30pm - 3:37pm PT
The Importance & Impact of Team-Based Care
Sunday, November 2, 2025
8:14am - 8:21am PT